Pharmacokinetics, Safety and Tolerability of Twice-Daily Aclidinium Bromide/Formoterol Fumarate Fixed Dose Combination in Chinese Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Clinical trial NCT03276078 · COMPLETED
Trial details
- NCT number
- NCT03276078
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-23
- Primary completion
- 2018-06-12
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.